Long-term Follow-Up Study on Gene Therapy Adverse Events in Pediatric Oncology

This long-term follow-up study is crucial for understanding the delayed adverse events associated with gene therapies in pediatric patients. The findings could significantly impact regulatory scrutiny and clinical practices, shaping the future landscape of gene therapy development.

Humanexa recommends Monitor.

Key milestones include interim results on adverse events and any regulatory changes prompted by the findings.